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Previously, we demonstrated induction of a unique macrophage prothrombinase during infection of BALB/cJ
mice by mouse hepatitis virus strain 3 (MHV-3). By immunologic screening, a clone representing this pro-
thrombinase was isolated from a cDNA library and sequenced. The sequence identified this clone as repre-
senting part of a gene, musfiblp, that encodes a fibrinogen-like protein. Six additional clones were isolated, and
one clone, p11-3-1, encompassed the entire coding region of musfiblp. Murine macrophages did not constitu-
tively express musfiblp but, when infected with MHV-3, synthesized musfiblp-specific mRNA. musfiblp mRNA
induction was earlier and significantly greater in BALB/cJ than A/J macrophages. Prothrombinase activity was
demonstrated when musfiblp was expressed from p11-3-1 in RAW 264.7 cells. These data suggest that musfiblp
encodes the MHV-induced prothrombinase.
Mouse hepatitis virus strain 3 (MHV-3), a member of the
coronavirus family, causes a strain-dependent spectrum of dis-
ease in inbred strains of mice (16, 29). BALB/cJ and C57BL/6J
mice develop a fatal hepatitis which is characterized patholog-
ically by sinusoidal thrombosis and associated hepatocellular
necrosis (2, 16, 17). C3H mice survive the acute infection and
develop a chronic inflammatory disease of the liver; A/J mice
are susceptible to infection but do not develop pathological
lesions in the liver or biochemical evidence of hepatic necrosis.
MHV-3 replicates in all four strains of mice, suggesting that
additional factors may be required for hepatic injury. Several
lines of evidence suggest that stimulation of the immune co-
agulation system by MHV-3 participates in the disease process.
First, induction of monocyte/macrophage procoagulant activity
(PCA) during MHV-3 infection correlates with the severity of
the disease (18, 21). Second, there is a genetic linkage between
induction of PCA in response to MHV-3 in vitro and in vivo
and susceptibility to liver disease (4). Finally, treatment of
mice with a monoclonal antibody to the MHV-3-induced PCA,
a direct prothrombinase, prevents the lethality associated with
MHV-3 infection (8). The MHV-3-induced PCA differs from
the recently defined tissue factor, a 47-kDa protein translated
from a 2.3-kb RNA, in that the MHV-induced PCA is depen-
dent on prothrombin and fibrinogen for its activity, in contrast
to tissue factor, which is dependent only on factor VII for its
activity (20, 22, 27). Tissue factor is known to be expressed by
monocytes, macrophages, fibroblasts, and endothelial cells but
is not induced by MHV-3 infection. To date, only monocytes
and macrophages have been shown to express PCA in response
to MHV-3 infection (16).
In this study, we report the molecular cloning and sequenc-
ing of a cDNA isolated from a library prepared from macro-
phages which had been infected with MHV-3. The sequence of
this cDNA is essentially identical to a previously described
sequence corresponding to a gene encoding a mouse fibrino-
gen-like protein (musfiblp) (12). musfiblp was originally de-
scribed as a cytotoxic T-cell (CTL)-specific gene which was
constitutively expressed. In contrast, in macrophages, musfiblp
is not normally expressed, but following MHV-3 infection, its
expression is upregulated. When the cDNA containing the
entire coding region of musfiblp was expressed in the RAW
264.7 cell line, a prothrombinase activity was detected by both
a one-stage clotting assay and cleavage of 125I-labeled pro-
thrombin.
MATERIALS AND METHODS
Mice. Female BALB/cJ and A/J mice, 6 to 8 weeks of age, were purchased
from Jackson Laboratories (Bar Harbor, Maine) and housed in the animal
facilities at the University of Toronto and the University of Texas Health Sci-
ences Center, Houston. They were fed a standard chow diet and water ad libitum
prior to and during the studies. Representative animals were tested for prior
exposure to MHV by enzyme-linked immunosorbent assay (ELISA) or indirect
immunofluorescent assays; anti-MHV antibodies were not detectable by these
methods.
Cells. Peritoneal macrophages were harvested from A/J and BALB/cJ mice 4
days after intraperitoneal administration of 1.5 ml of 3% thioglycolate (Difco
Laboratories, Detroit, Mich.) as previously described (16). Macrophages were
greater than 95% pure, as determined by morphology, nonspecific esterase stain,
and staining with MAC-1 antibody (8). Viability exceeded 98% by trypan blue
dye exclusion. RAW 264.7, a BALB/cJ macrophage-derived continuous cell line,
was obtained from the American Type Culture Collection (ATCC) and propa-
gated in Dulbecco’s modified Eagle’s medium (DME) fortified with 10% fetal
bovine serum (24). BSC1 cells, a monkey kidney cell line, and RK13, a rabbit
kidney cell line, were obtained from the ATCC and similarly maintained in
culture (13, 25).
Virus. MHV-3 was grown and titrated as described previously (16). A recom-
binant vaccinia virus expressing the bacteriophage T3 RNA polymerase
(VVT3pol) was generously provided by M. Esteban, Department of Biochemis-
try, State University of New York Downstate Medical Center, Brooklyn, N.Y.,
and propagated in RK13 cells and titrated on BSC1 cells (25).
Production and screening of the cDNA library. BALB/cJ peritoneal macro-
phages were infected with MHV-3, and at 6 h postinfection, RNA was extracted
with guanidium hydrochloride and precipitated with ethanol (6). Polyadenylated
RNA was selected by chromatography over an oligo(dT)-cellulose column. A
random-primed cDNA library was constructed by Stratagene in the vector
lambda ZAPII by standard methods (26). The amplified library was screened by
plaque immunoassay with the monoclonal antibody 3D4.3 as the primary immu-
nological reagent and 125I-labeled staphylococcal protein A as a secondary re-
agent. Plaques testing positive were diluted, replaqued, and retested as described
above until they were clonally isolated. Bluescript phagemids were rescued by
excision from lambda ZAPII by superinfection with the helper phage R408 at a
* Corresponding author. Mailing address: Dept. of Pathology and
Laboratory Medicine, University of Texas Medical School, P.O. Box
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multiplicity of 10. Rescued bacteriophage was then used to infect Escherichia coli
XL1 cells, and ampicillin-resistant colonies were selected. Plasmid DNA was
prepared by using the Wizard miniprep kit (Promega, Madison, Wis.). The
presence of inserts was verified by restriction enzyme digestion and agarose gel
electrophoresis. The sequence was determined by using a nested deletion (10)
and a primer-directed strategy by cycle sequencing on an automated DNA
sequencer (model 373A; Applied Biosystems) with dideoxy dye terminator
chemistry. A consensus sequence was generated by using the Genetics Computer
Group software (2). The GenBank and EMBL databases were searched with the
FASTA and BLAST programs. Additional clones corresponding to the musfiblp
insert within p1360-23 were identified by plaque hybridization. The probe used
for screening was synthesized by PCR from a plasmid template, p1360-23, car-
rying our initial clone, and was then labeled by random priming. The oligonu-
cleotides used for PCR corresponded to positions 860 to 877 and 2084 to 2063
(negative sense) in Fig. 2. Phage was clonally isolated, and plasmids were excised
as described above. The sequence was determined and analyzed as described
above to produce a full consensus sequence.
RNA isolation and analysis. Total RNA was isolated from both MHV-infected
and uninfected macrophages and cell lines with guanidium hydrochloride (6).
RNA (5 to 10 mg) was resolved by electrophoresis through a 0.8% agarose gel in
MOPS (morpholinepropanesulfonic acid)-formaldehyde, transferred to a nylon
membrane in 203 SSPE (13 SSPE is 0.18 M NaCl, 10 mM NaH2PO4, and 1 mM
EDTA [pH 7.4]), and UV cross-linked (26). The membrane was prehybridized
for 6 h at 428C with denatured salmon sperm DNA (100 mg/ml in 50% form-
amide–53 SSPE–53 Denhardt’s solution (26)–0.5% sodium dodecyl sulfate
[SDS]). A DNA probe identical to that used to rescreen the library was labeled
by random priming and added to the hybridization reaction mix, and hybridiza-
tion was continued for 18 h at 428C. The membrane was then washed three times
at room temperature with 53 SSPE–0.5% SDS for 10 min. Three additional
washes were carried out with 13 SSPE–0.5% SDS at 378C. The membrane was
washed three additional times with 0.13 SSPE–1.0% SDS at 658C and then
autoradiographed. Quantitation was performed with a Betagen scanner.
Transient expression of musfiblp. Replicate cultures of 106 RAW 264.7 cells
were either infected with MHV-3 at a multiplicity of infection (MOI) of 5,
infected with VVT3pol at an MOI of 10, coinfected with both viruses, or mock
infected. Immediately after viral infection, the cells were washed and transfected
by the lipofectin procedure (GIBCO BRL) with 10 mg of p11-3-1. The transfec-
tion mixture was allowed to incubate for 2.5 h at 378C. The lipofectin-containing
medium was removed and replaced with DME containing 10% fetal bovine
serum, and the cells were incubated until 24 h postinfection. The medium was
removed, and the monolayers were washed once with DME and frozen in 1 ml
of DME at 2708C until assayed for PCA.
PCA. The cell lysates were evaluated for PCA expression in a one-stage
clotting assay as previously described (14). Following incubation, samples to be
assayed for PCA were subjected to three cycles of freeze-thawing to obtain
maximal total cellular PCA. Samples were assayed for their ability to shorten the
spontaneous clotting time of normal citrated human platelet-poor plasma. Ad-
ditional studies were performed with human plasmas which were congenitally
deficient in coagulation factor VII, X, or II (Helena Laboratories, Beaumont,
Tex.) to determine the nature (factor dependence) of the procoagulant. Milli-
units of PCA were assigned by reference to a standard curve generated with
serial log dilutions of a standard rabbit brain thromboplastin (Dade Division,
American Hospital Supply Co., Miami, Fla.). The medium and reagents were
without activity.
Factor X and prothrombin were isolated from Cohn fraction III as previously
described (23). For assay of cleavage, prothrombin was radioiodinated enzymat-
ically with immobilized lactoperoxidase and glucose oxidase (Enzymobeads; Bio-
Rad, Richmond, Calif.) to a specific activity of 6.2 mCi/mg. To 25 ml of cellular
homogenates, 10 ml of 125I-prothrombin and 10 ml of 25 mM CaCl2 were added.
The reaction was allowed to proceed at 378C for 30 min. Human factor Xa (0.5
mg/ml), in the presence of homogenates of 106 unstimulated macrophages, was
used as a positive control for 125I-prothrombin cleavage. Each reaction mixture
was electrophoresed on a 10% polyacrylamide gel. Following electrophoresis, the
gels were fixed, dried, and subjected to autoradiography.
RESULTS
Identification of PCA-specific cDNA clones. Peritoneal exu-
date macrophages from BALB/cJ mice were infected with
MHV-3, and polyadenylated RNA was purified at 6 h postin-
fection. Random-primed cDNA was synthesized, and a cDNA
library was prepared by using the Stratagene vector lambda
ZAPII. The library was initially screened by a plaque immu-
noassay with the monoclonal antibody 3D4.3, which has been
shown previously to be specific for the MHV-3-induced PCA
(8). A plaque expressing an immunoreactive protein were se-
lected and retested repeatedly until a clonally isolated phage
was obtained. A plasmid carrying the cDNA was propagated
after excision and rescue with helper phage R408. The se-
quence of this clone, p1360-23 (1.25 kb), was compared with
sequences in the GenBank and EMBL databases and was
identical to a portion of exon 2 of musfiblp, with the exception
of one nucleotide. A series of six additional clones were iden-
tified by plaque hybridization with a probe prepared from
p1360-23, clonally isolated, and propagated as plasmids (Fig.
1A).
A consensus sequence from portions of these six clones and
p1360-23 was assembled by the strategy shown in Fig. 1B. A
database search with the sequence of our largest clone, p11-
3-1, revealed that the protein encoded by the cDNA sequence
of mouse PCA was identical to a gene product from both
cDNA and genomic T-cell libraries that encodes a fibrinogen-
like protein, musfiblp (Fig. 2), which is composed of two exons
(12). The clone, p11-3-1, is 2,451 bp in length, encompasses the
entire coding region of exon 1 and exon 2 of musfiblp, and
appears to differ from the published sequence by 1 bp at
position 1138 (C3G), which changes an alanine to a glycine in
the translated protein. The 59-most 108 nucleotides of p11-3-1
diverge from the 59 untranslated region of musfiblp. A search
of the nonredundant sequence database at the National Li-
brary of Medicine with the BLASTN program demonstrated
that these 108 nucleotides correspond to positions 3658 to 3765
in an uncharacterized 6,379-nucleotide cDNA (GenBank ac-
cession number D29640) isolated from a human immature
myeloid cell line. For reasons discussed below, we believe that
this 108-nucleotide sequence represents a cloning artifact.
Northern (RNA blot) analysis of PCA mRNA. To determine
if musfiblp transcripts were induced by infection of macro-
phages with MHV-3, macrophages from BALB/cJ and A/J
mice were infected with MHV-3, and total RNA was extracted
at various times postinfection. RNA was electrophoresed, blot-
ted, and hybridized with a musfiblp-specific probe. RNA hy-
bridizing to the musfiblp-specific probe was not detected in
uninfected macrophages from either A/J or BALB/cJ mice. In
macrophages from BALB/cJ mice, musfiblp-specific RNA was
first detected at 4 h postinfection, peaked at 6 h, decreased
thereafter, and returned to baseline by 24 h (Fig. 3). The
predominant RNA observed was approximately 4 kb in size,
consistent with the previously reported size of musfiblp tran-
scripts in CTL. Longer exposures revealed the presence of
small amounts of longer transcripts (data not shown). Quan-
titation by betascanning indicated that an approximately 80-
fold induction of the 4-kb transcript was obtained at 6 h postin-
fection (Fig. 4). In A/J macrophages, a significant but lesser
induction of musfiblp-specific transcripts was observed. The
maximum level of induction, 39-fold, was obtained at a later
time, 12 h postinfection (Fig. 3 and 4).
PCA of transfected cell lysates. To prove that the gene
product of musfiblp had prothrombin-cleaving activity, a gene
transfer strategy was employed. To express the musfiblp pro-
tein, we used a macrophage cell line, RAW 264.7, which con-
tained very low levels of musfiblp transcripts (data not shown)
and expressed no functional PCA, either constitutively, follow-
ing stimulation with lipopolysaccharide (LPS), or following
infection with MHV-3 (Table 1 and Fig. 5). For expression of
the musfiblp protein, we exploited the presence of an upstream
T3 promoter in the p11-3-1 plasmid. RAW 264.7 cells were
transfected with plasmid p11-3-1 and infected with a recombi-
nant vaccinia virus expressing the T3 polymerase (VVT3pol).
PCA was measured in a one-stage clotting assay and by the
ability of the gene product to cleave prothrombin directly to
the active moiety, thrombin (14). Uninfected and nontrans-
fected RAW cells expressed low basal PCA (Table 1). No
augmentation was observed even following stimulation with
MHV-3 or LPS. Infection with VVT3pol by itself or in com-
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bination with MHV-3 resulted in a modest, although statisti-
cally significant, augmentation in PCA. Transfection of p11-3-1
in the absence of VVT3pol to drive the T3 promoter resulted
in a similar low level of activity. However, the combination of
VVT3pol and p11-3-1 induced a marked increase in PCA,
suggesting that musfiblp expression is necessary for functional
PCA. The combination of VVT3pol, p11-3-1, and MHV-3
resulted in a small, reproducible, but statistically not significant
further increase in PCA, suggesting that MHV infection may
further upregulate PCA, although the mechanism for this is
not clear.
To confirm that the PCA was indeed a prothrombinase, the
cell lysates were added to 125I-prothrombin, and cleavage to
thrombin was monitored by SDS-PAGE (Fig. 5). The results
obtained exactly paralleled those obtained in the one-stage
clotting assay. Only RAW 264.7 cells in which the expression
of musfiblp was driven by VVT3pol (Fig. 5, lanes 5 and 7)
demonstrated prothrombin cleavage. Neither infection with
VVT3pol (Fig. 5, lane 4) nor transfection with p11-3-1 by itself
(lane 6) resulted in prothrombin cleavage. The pattern of
cleavage was identical to that observed with the physiologic
cleavage observed following addition of factor Xa (Fig. 5, lane
9).
DISCUSSION
In this study, using a monoclonal antibody to MHV-3-in-
duced PCA (3D4.3), we have isolated a molecular clone cor-
responding to a mouse fibrinogen-like gene (musfiblp) (8, 12).
A series of additional clones was identified, including a clone
which contained the entire musfiblp coding sequence (p11-3-
1). Although the sequence was nearly identical to the pub-
lished sequence of musfiblp, there were two differences. The
first was a single base substitution at position 1138, corre-
sponding to an amino acid change of an alanine to a glycine in
the protein (Fig. 2). This represents a conservative change
which should result in no significant alteration of the protein
structure. The second difference was a divergence between the
first 108 nucleotides of p11-3-1 from the published musfiblp 59
untranslated sequence. musfiblp transcripts were shown to be
upregulated in MHV-3-infected BALB/cJ and A/J macro-
phages. However, the kinetics and degree of induction of
musfiblp RNA were earlier and significantly greater in macro-
phages from BALB/cJ mice than in macrophages from A/J
mice. Furthermore, the kinetics of accumulation of musfiblp
mRNA in BALB/cJ macrophages paralleled the expression of
functional PCA. When the entire coding region of musfiblp
(p11-3-1) was expressed by a coupled vaccinia virus-bacteri-
ophage system in RAW 264.7 cells, a cell line which did not
express functional PCA either constitutively or after infection
with MHV, a marked functional PCA response was observed.
The finding of a 108-base divergence from the published
sequence was surprising. Two explanations for this divergence
are possible. First, these 108 bases could represent a previously
undescribed upstream exon within musfiblp. A second expla-
nation is that this represents a cloning artifact. Genomic clones
encompassing approximately 24 kb of upstream sequence, gen-
erously provided by H. Saito (Dana Farber Cancer Institute),
FIG. 1. Schematic map of cDNA clones and the sequencing strategy. (A) Relative size and relationship of each clone. The schematic maps of overlapping cDNA
clones representingmusfiblp were identified from a Stratagene lambda ZAPII library. The library was screened as described in the text, and seven clones were identified.
(B) The sequencing was performed with a nested deletion and a primer-directed strategy. Each sequencing reaction is depicted by an arrow showing the direction of
sequencing.
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FIG. 2. Consensus nucleotide and predicted amino acid sequences of cDNAs. The sequence shows identity to musfiblp except for the boxed first 108 bases and one
nucleotide change at position 1138 (from a C to a G), to change the predicted amino acid alanine to a glycine. The codon encoding the glycine in our sequence is
indicated by boldface type. The nucleotide at position 1138 is underlined, and the previously reported C at this position is shown above our sequence. The resulting
amino acid change is shown below our sequence.
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were examined for the presence of these 108 bases by blot
hybridization, and no signal corresponding to the sequence was
identified. Additional cDNA clones containing the 108 bases
embedded in the center of their sequences have been identified
in our cDNA library. These clones contain a single open read-
ing frame, but none of them contain musfiblp-related se-
quences. A search of the GenBank database revealed that the
sequences represented by these cDNA clones is almost iden-
tical to an otherwise uncharacterized human mRNA isolated
from an immature myeloid cell line. Therefore, it is unlikely
that these 108 nucleotides are related to musfiblp, and they
probably represent a cloning artifact.
Examination of the predicted protein structure of the
musfiblp product showed 36% sequence similarity with the
C-terminal portion of the beta and gamma subunits of fibrin-
ogen, similar to other members of the fibrinogen family of
proteins (12). In a previous report, it was suggested that the
musfiblp protein does not contain the amino acid residues
corresponding to a thrombin-sensitive site for the release of a
fibrinopeptide or a site for cross-linking or interaction with
platelets (5). It was further suggested that a signal peptide was
necessary for transport of the protein into the endoplasmic
reticulum, consistent with this being a secreted protein. The
authors further suggested that the musfiblp product may
dimerize or associate with other proteins to form a three-
stranded coiled coil. We have previously shown by Western
blot that PCA is a disulfide-linked dimer (8). Thus, these ob-
servations are compatible. The predicted molecular size, 49
kDa, of the nonglycosylated musfiblp protein is in keeping with
the approximate 70-kDa size of the prothrombinase expressed
in macrophages following MHV stimulation.
Our interest in this molecule is its ability to cleave prothrom-
bin to thrombin independent of coagulation factors XII, VIII,
VII, X, and V for its activity, which is characteristic of a direct
prothrombinase (27). Previously, we suggested that the MHV-
induced prothrombinase was a serine protease, based on in-
hibitor analysis. Examination of the predicted amino acid se-
quence of the musfiblp product failed to reveal any classical
proteinase motifs. However, this is not unprecedented. Re-
cently, the active site of interleukin-1b converting enzyme was
determined to be contained within a previously undescribed
cysteine proteinase motif (28). The determination of the
musfiblp proteinase active site awaits site-directed mutagenesis
experiments.
Originally, musfiblp was isolated from a CTL cell line and
was shown to be constitutively expressed in CTL but not in
FIG. 3. musfiblp RNA expression in macrophages from A/J and BALB/cJ
mice following MHV-3 infection. Thioglycolate-elicited peritoneal macrophages
(.96% MAC-1 positive) from A/J and BALB/cJ mice were mock infected (time
zero) or infected (time 2 to 24 h) with MHV-3 at an MOI of 1. Total RNA was
extracted at the various time points postinfection (p.i.) as indicated, and 15 mg of
total RNA was resolved on a formaldehyde gel, blotted onto Nytran, and hy-
bridized with the musfiblp cDNA probe, p1360-23, as described in Materials and
Methods. The relative equivalence of the amount and integrity of mRNA in each
sample was verified by hybridization with an a-tubulin cDNA (data not shown).
FIG. 4. Induction of musfiblp mRNA in MHV-infected A/J and BALB/cJ
mouse macrophages. Peritoneal macrophages were collected and infected with
MHV-3, and total RNA was extracted at various times postinfection. RNA was
electrophoresed, transferred to a Nytran membrane as described in the legend to
Fig. 3, hybridized with a cDNA probe made from p1360-23, and quantitated with
a Betagen scanner. }, A/J macrophage RNA; F, BALB/cJ macrophage RNA.
FIG. 5. Expression of musfiblp correlates with prothrombinase activity. Ho-
mogenates (0.05 ml) of replicate cultures of 106 RAW 264.7 cells either infected
with MHV-3 alone at an MOI of 5, infected with VVT3pol alone at an MOI of
10, coinfected with both viruses, or mock infected in normal saline were incu-
bated for 60 min at 378C with 0.01 ml of 125I-prothrombin (100 nM) and 0.01 ml
of CaCl2 (25 mM). SDS and EDTA were added, and the samples were electro-
phoresed on an SDS–10% polyacrylamide slab gel and displayed by autoradiog-
raphy. Lane 1, 125I-prothrombin alone; lane 2, 125I-prothrombin incubated with
RAW cells infected with MHV-3; lane 3, 125I-prothrombin incubated with RAW
cells stimulated with LPS for 6 h; lane 4, 125I-prothrombin incubated with RAW
cells infected with VVT3pol; lane 5, 125I-prothrombin incubated with RAW cells
infected with both VVT3pol and p11-3-1; lane 6, 125I-prothrombin incubated
with RAW cells infected with p11-3-1; lane 7, 125I-prothrombin incubated with
RAW cells infected with VVT3pol, MHV-3, and p11-3-1; lane 8, 125I-prothrom-
bin incubated with VVT3pol and MHV-3; lane 9, 125I-prothrombin incubated
with Russel’s viper venom; lane 10, 125I-prothrombin incubated with mock-
infected RAW cells.
TABLE 1. Induction of PCA by MHV-3a
Stimulus Mean PCA (mU/10
6
macrophages) 6 SD
Control 16 6 2
MHV-3 18 6 4
LPS 18 6 1
Vaccinia virus vector only 54 6 7
Vaccinia virus vector 1 p11-3-1 795 6 143
p11-3-1 83 6 40
Vaccinia virus vector 1 p11-3-1 1 MHV-3 1,120 6 255
Vaccinia virus vector 1 MHV-3 85 6 35
a Data represent the mean 6 standard deviation of four experiments done in
triplicate. Macrophages are the RAW cell line.
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B-cell lines, T helper cells, keratinocytes, mouse brain, or fi-
broblasts. Our data show that musfiblp RNA was not constitu-
tively expressed in macrophages but, following MHV infection,
was markedly upregulated. Although we did not examine CTL
specifically, lymphocytes recovered from popliteal lymph
nodes showed only small amounts of constitutively expressed
musfiblp RNA, and MHV infection did not result in further
augmentation (data not shown). Although resistant A/J mice
show transcription of musfiblp, they express no functional
PCA. There are several possibilities that could explain this
observation. First, a posttranslational modification may be re-
quired for functional activity, and this may not occur in A/J
mice. Second, functional activity may require additional factors
yet to be identified. Third, it is possible that the sequence of
musfiblp in A/J mice precludes translation of a functional pro-
tein. Previous work has implicated the macrophage as being of
central importance in resistance and susceptibility to MHV-3
(1). Furthermore, we have established a correlation between
susceptibility to lethal infection and induction of PCA by mac-
rophages (3). The recent production of monoclonal antibodies
to PCA in our laboratory and the demonstration that passive
transfer of these antibodies to susceptible mice confers resis-
tance to MHV-3 argue strongly for a role for PCA in the
pathogenesis of MHV-3 (19). The sequela of prothrombinase
production is generation of thrombin. Thrombin is the central
bioregulatory enzyme in hemostasis and is responsible for con-
version of fibrinogen to fibrin and for activation of coagulation
factors V, VII, and XIII (7). In addition, it is a potent activator
of platelets, either alone or in synergism with other agents, and
may interact directly with endothelial cells, causing vasocon-
striction (9) and mediating leukocyte adherence (11), all of
which are prominent features of MHV infection (15).
In conclusion, in this study, we have demonstrated that fol-
lowing MHV-3 infection, musfiblp RNA is markedly upregu-
lated in macrophages from susceptible BALB/cJ mice. In
transfection experiments, we have shown that expression of
this gene results in the elaboration of prothrombinase activity.
Further experiments on the mechanism of regulation of this
gene will lead to further understanding of the role of musfiblp
in the pathogenesis of MHV-3 infection.
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